Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank79
3Y CAGR-18.4%
5Y CAGR+4.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-18.4%/yr
vs +47.0%/yr prior
5Y CAGR
+4.2%/yr
Recent deceleration
Acceleration
-65.4pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2025$44.49M+10.0%
2024$40.45M-53.3%
2023$86.66M+5.8%
2022$81.88M+18.9%
2021$68.84M+90.4%
2020$36.16M+98.8%
2019$18.19M+3.6%
2018$17.56M+31.6%
2017$13.34M-53.2%
2016$28.53M-